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DObjectives:We hypothesize that concomitant tricuspid annuloplasty in patients with tricuspid annular dilatation
who undergo mitral valve repair could prevent progression of tricuspid regurgitation and right ventricular re-
modeling.
Methods: In 2002, 80 patients underwent mitral valve repair. Concomitant tricuspid annuloplasty was per-
formed in 13 patients with grade 3 or 4 tricuspid regurgitation. In 2004, 102 patients underwent mitral valve
repair. Concomitant tricuspid annuloplasty was performed in 21 patients with grade 3 or 4 tricuspid regur-
gitation and in 43 patients with an echocardiographically determined tricuspid annular diameter of 40 mm
or greater. Patients underwent transthoracic echocardiographic analysis preoperatively and at the 2-year
follow-up.
Results: In the 2002 cohort right ventricular dimensions did not decrease (right ventricular long axis, 69  7 vs
70  8 mm; right ventricular short axis, 29  7 vs 30  7 mm); tricuspid regurgitation grade and gradient re-
mained unchanged. In the 2004 cohort right ventricular reverse remodeling was observed (right ventricular long
axis, 71 6 vs 69 9 mm; right ventricular short axis, 29 5 vs 27 5 mm; P<.0001); tricuspid regurgitation
diminished (1.6  1.0 vs 0.9  0.6, P<.0001), and transtricuspid gradient decreased (28  13 vs 23  15 mm
Hg, P ¼ .021). Subanalysis of the 2002 cohort showed that in 23 patients without grade 3 or 4 tricuspid regur-
gitation but baseline tricuspid annular dilatation, the degree of tricuspid regurgitation was worse at the 2-year
follow-up. Moreover, this caused right ventricular dilatation. Subanalysis of the 2004 cohort demonstrated
reverse right ventricular remodeling and decreased tricuspid regurgitation in 43 patients with preoperative
tricuspid annular dilatation who underwent tricuspid annuloplasty.
Conclusions: Concomitant tricuspid annuloplasty during mitral valve repair should be considered in patients
with tricuspid annular dilatation despite the absence of important tricuspid regurgitation at baseline because
this improves echocardiographic outcome. (J Thorac Cardiovasc Surg 2011;141:1431-9)In patients scheduled for mitral valve surgery, tricuspid re-
gurgitation (TR) is not uncommon. A decrease in TR has
been noted after mitral valve surgery because of reduced
right ventricular pressure or volume overload. Still, pro-
gression of TR without left-sided valvular dysfunction or
de novo TR can be observed during follow-up.1 In particu-
lar, TR after successful left-sided valve surgery has been re-
ported in up to 74% of patients at long-term follow-up and
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The Journal of Thoracic and Carvalve repair with an annuloplasty ring in patients with
moderate or severe TR undergoing left-sided valve surgery
has been shown to improve (event-free) survival.4 Various
authors have suggested that at the time of mitral valve sur-
gery, tricuspid annuloplasty should be considered when tri-
cuspid annular dilatation is present.2,5-8 Recently published
European Society of Cardiology guidelines recommend
tricuspid valve repair in case of left-sided valve surgery
when there is severe TR but also when there is annular di-
latation (40 mm) of the tricuspid valve.9 The American
College of Cardiology and American Heart Association
guidelines state that tricuspid annuloplasty might be con-
sidered in patients undergoing mitral valve surgery when
there is tricuspid annular dilatation.10 The absence of TR
and right ventricular reverse remodeling after restrictive tri-
cuspid annuloplasty would support this approach. However,
echocardiographic studies addressing these specific ques-
tions are scarce. Accordingly, we evaluated echocardio-
graphic outcomes at a 2-year follow-up in patients with
organic or functional mitral regurgitation who underwent
mitral valve repair in 2002 and 2004, respectively.diovascular Surgery c Volume 141, Number 6 1431
FIGURE 1. The tricuspid annular diameter is measured from the preoper-
ative, transthoracic, apical 4-chamber view in late diastole, as recommen-
ded by Foale and associates.13 In this example the tricuspid annulus (45
mm) is dilated.
Abbreviation and Acronym
TR ¼ tricuspid regurgitation
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DMATERIALS AND METHODS
Study Population
The patient population consisted of 182 patients who underwent mitral
valve repair in 2002 or 2004 and completed a 2-year follow-up echocardio-
graphic analysis.
The 2002 cohort included 80 consecutive patients with severe mitral
valve regurgitation who underwent mitral valve repair and completed the
2-year echocardiographic follow-up. The mechanism of mitral regurgita-
tion was organic in 71% of cases and functional in 29% of cases. Coronary
artery bypass graft surgery was performed simultaneously in 24% of
patients.
The 2004 cohort included 102 consecutive patients with severe mitral
regurgitation who underwent mitral valve repair and completed the 2-
year echocardiographic follow-up. The mechanism of mitral regurgitation
was organic in 50% of cases and functional in 50% of cases. Coronary
artery bypass graft surgery was performed simultaneously in 24% of
patients. Our institution’s ethics committee approved conducting this retro-
spective study and waived the need for individual consent.
Clinical Assessment
Every patient underwent clinical assessment by a physician who was
blinded to the echocardiographic data. New York Heart Association class
and Canadian Cardiac Society score were used at baseline and at the 2-
year follow-up.
Echocardiography
The clinical echocardiographic evaluation was as follows. A transtho-
racic echocardiogram was performed within 5 days before the operation
and at the 2-year follow-up. Patients were imaged in the left lateral decu-
bitus position by using a commercially available system (Vingmed Sys-
tem Five or Vivid Seven; GE, Horten, Norway). Images were obtained
with a 3.5-MHz transducer at a depth of 16 cm in the parasternal and api-
cal views (standard long-axis, 2-chamber, and 4-chamber images). The
left atrial diameter and left ventricular dimensions (end-systolic and
end-diastolic diameters) were determined from parasternal M-mode ac-
quisitions. Color flow was applied in the apical views to evaluate mitral
regurgitation and TR. The severity of mitral regurgitation was character-
ized as mild (1; jet area/left atrial area,<10%), moderate (2; jet area/left
atrial area, 10%–20%), moderately severe (3; jet area/left atrial area,
20%–45%), and severe (4; jet area/left atrial area,>45%).11 The severity
of TR was characterized as trivial (1; jet area/right atrial area,<10%),
mild (2; jet area/right atrial area, 10%–20%), moderate (3; jet area/right
atrial area, 20%–33%), and severe (4; jet area/right atrial area, 33%).12
The trans-TR gradient was quantified (modified Bernoulli equation) by
using continuous-wave Doppler scanning. From the apical 4-chamber
view, the ultrasound beam was oriented to obtain the maximum dimen-
sions of the right ventricular chamber. Measurements were made of the
right ventricular long and short axis, as well as the tricuspid valve annu-
lus.13 The tricuspid annulus was measured in the transthoracic apical 4-
chamber view in late diastole at the time of maximal tricuspid opening
(Figure 1).Surgical Procedure
The procedures were performed with the use of normothermic cardio-
pulmonary bypass with intermittent antegrade warm blood cardioplegia
for myocardial protection. After median sternotomy, patients with an1432 The Journal of Thoracic and Cardiovascular Surindication for revascularization underwent coronary artery bypass graft-
ing; for patients younger than 70 years, a strategy of total arterial revascu-
larization was used. Next, the right atrium was opened, and after a vertical
transseptal approach, mitral valve repair was performed after thorough
intraoperative valve analysis. In the case of organic disease, mitral valve
reconstruction was conducted by using standard Carpentier techniques.14
Mitral annuloplasty ring size (Carpentier–Edwards Physioring; Edwards
Lifesciences, Irvine, Calif) was determined by means of standard mea-
surement of the height of the anterior leaflet. In the case of functional mi-
tral regurgitation, stringent downsizing by 2 ring sizes was performed. In
the 2002 cohort tricuspid annuloplasty was performed only when the pre-
operative echocardiogram demonstrated grade 3 or 4 TR. In the 2004
cohort tricuspid annuloplasty was performed when the preoperative echo-
cardiogram demonstrated grade 3 or 4 TR or in any case when tricuspid
annulus enlargement (40 mm) had been observed, as proposed re-
cently.15 A Carpentier–Edwards Classic annuloplasty ring (18%) or Ed-
wards MC3 annuloplasty ring (82%; both manufactured by Edwards
Lifesciences) was used. The ring size was determined by means of stan-
dard measurement of the surface of the anterior leaflet in organic cases.
In functional cases a restrictive (1 size under) annuloplasty was per-
formed. After weaning from cardiopulmonary bypass, the result of the
valve reconstructions was checked with transesophageal echocardio-
graphic analysis.
Statistical Analysis
Continuous data were expressed as means  standard deviations and
compared by using the Student t test for paired and unpaired data when ap-
propriate. Comparison of categorical data was performed with c2 analysis.
Comparisons within each cohort of patients were performed by using the
Student t test or nonparametric tests for paired and unpaired data, as appro-
priate. In addition, each cohort was divided into 3 subgroups: patients with
TR grade 3 or 4, patients without TR grade 3 or 4 but with tricuspid annular
dilatation of 40 mm or greater, and patients without TR grade 3 or 4 or tri-
cuspid annular dilatation of 40 mm or greater. Comparisons among the 3
different subgroups were performed with 1-way analysis of variance or
the Kruskal–Wallis test, as appropriate. All statistical analyses were per-
formed with SPSS software (version 15.0; SPSS, Inc, Chicago, Ill).gery c June 2011
TABLE 2. Baseline echocardiographic characteristics
2002 cohort
(n ¼ 80)
2004 cohort
(n ¼ 102) P value
Left atrial diameter (mm) 50  10 47  7 .092
LV end-diastolic diameter (mm) 61  9 59  8 .25
LV end-systolic diameter (mm) 42  11 42  11 .93
Fractional shortening (%) 31  12 29  13 .84
Mitral regurgitation grade 3.4  0.7 3.2  0.7 .20
RV long axis (mm) 69  7 72  8 .15
RV short axis (mm) 29  7 29  5 .98
Tricuspid valve annulus (mm) 38  7 39  5 .34
Tricuspid regurgitation grade 1.6  1.0 1.6  1.0 .85
Transtricuspid gradient (mmHg) 25  10 28  13 .11
LV, Left ventricular; RV, right ventricular.
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Baseline Characteristics
Baseline clinical characteristics of the 2002 and 2004 co-
horts are presented in Table 1. There is a male predominance
in both cohorts, and 34% of the patients have a history of
myocardial infarction. Patients from the 2004 cohort were
older than patients from the 2002 cohort. All patients
were receiving optimized medical treatment. Risk factors,
medical history, and functional class were similar. Preoper-
ative echocardiographic characteristics are presented in
Table 2. Left ventricular dimensions and function, as well
as severity of mitral regurgitation, were comparable be-
tween the 2 cohorts. TR was similar between both cohorts,
as were right ventricular dimensions.C
DSurgical Details
All patients underwent successful mitral valve repair (ie,
no residual mitral regurgitation and a coaptation length
8 mm). The mitral mean ring size used was 30  4 mm
in the 2002 cohort compared with 28  3 mm in the 2004
cohort. Tricuspid annuloplasty was performed in 13 (16%)
patients of the 2002 cohort and in 64 (63%) patients of the
2004 cohort. The tricuspid mean ring size used was 32  3
mm in the 2002 cohort compared with 29  2 mm in the
2004 cohort. Coronary artery bypass grafting was performed
in 19 patients of the 2002 cohort and 35 patients of the 2004
cohort. Cardiopulmonary bypass time and clamp time were
comparable between the groups: 173  52 versus 162  52
minutes and 119 44 versus 101 46minutes, respectively.ATwo-Year Follow-up
Clinical and echocardiographic 2-year follow-ups of the
entire 2002 and 2004 cohorts are presented in Tables 3 and
4. A significant difference in New York Heart Association
functional class was observed at follow-up. In both groups
the expected reduction of mitral regurgitation was notedTABLE 1. Baseline clinical characteristics
2002 cohort
(n ¼ 80)
2004 cohort
(n ¼ 102) P value
Men/women 44 (55%)/36 (45%) 62 (61%)/40 (39%) .50
Mean age  SD, y 60  15 66  12 .010
Arterial
hypertension
10 (13%) 20 (20%) .091
Diabetes 6 (8%) 10 (10%) .67
Severe COPD 6 (8%) 8 (8%) .99
Previous stroke 3 (4%) 3 (3%) .84
Previous infarction 19 (24%) 31 (30%) .19
Previous CABG 19 (24%) 35 (34%) .093
NYHA class 2.6  0.8 2.6  0.8 .49
CCS class 1.3  0.6 1.3  0.8 .61
SD, Standard deviation; COPD, chronic obstructive pulmonary disease; CABG, cor-
onary artery bypass grafting; NYHA, New York Heart Association; CCS, Canadian
Cardiac Society.
The Journal of Thoracic and Carafter surgical intervention. This observation was accompa-
nied by a matched reduction in left atrial and left ventricular
dimensions, indicating reverse remodeling after surgical in-
tervention. In the 2002 cohort, right ventricular dimensions,
TR grade, and gradient remained unchanged after surgical
intervention. In the 2004 cohort, the right ventricular di-
mensions decreased after surgical intervention accompa-
nied by a reduction in TR and transtricuspid gradient.
In summary, echocardiographic outcome at the 2-year
follow-up did not improve in the 2002 cohort patients
who did not undergo tricuspid annuloplasty in case of tri-
cuspid annular dilatation. In contrast, 2004 cohort patients
who underwent combined mitral valve repair and tricuspid
annuloplasty in case of severe TR or tricuspid annular dila-
tation demonstrated reverse right ventricular remodeling
and reduction of TR.Subgroup Analysis of the 2002 Cohort
At the 2-year follow-up, the expected reduction of mitral
regurgitation and left atrial and ventricular reverse remodel-
ing was also observed in the different subgroups of the 2002
cohort (Table 5). In 2002, only patients with a grade 3 or 4
TR underwent tricuspid valve annuloplasty. In these 13 pa-
tients TR was absent or mild at the 2-year follow-up, and
there was also a significant decrease of the transtricuspidTABLE 3. Two-year follow-up: Entire 2002 cohort
Baseline Follow-up P value
New York Heart Association class 2.6  0.8 1.4  0.6 <.0001
Canadian Cardiac Society class 1.3  0.6 1.0  0.2 <.001
LA diameter (mm) 50  10 43  8 <.0001
LV end-diastolic diameter (mm) 61  9 52  10 <.0001
LV end-systolic diameter (mm) 42  11 35  11 <.0001
Mitral regurgitation grade 3.4  0.7 0.7  0.8 <.0001
RV long axis (mm) 69  7 70  8 .301
RV short axis (mm) 29  7 30  7 .080
Tricuspid regurgitation grade 1.6  1.0 1.3  1.0 .211
Transtricuspid gradient (mm Hg) 25  10 23  9 .091
LA, Left atrial; LV, left ventricular; RV, right ventricular.
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TABLE 4. Two-year follow-up: Entire 2004 cohort
Baseline Follow-up P value
New York Heart Association class 2.6  0.8 1.8  0.8 <.0001
Canadian Cardiac Society class 1.3  0.8 1.1  0.2 <.001
LA diameter (mm) 48  7 44  7 <.0001
LV end-diastolic diameter (mm) 59  8 53  9 <.0001
LV end-systolic diameter (mm) 42  11 38  12 <.0001
Mitral regurgitation grade 3.3  0.5 0.8  0.8 <.0001
RV long axis (mm) 71  6 69  9 .001
RV short axis (mm) 29  5 27  5 <.0001
Tricuspid regurgitation grade 1.6  1.0 0.9  0.6 <.0001
Transtricuspid gradient (mm Hg) 28  13 23  15 .021
LA, Left atrial; LV, left ventricular; RV, right ventricular.
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Dgradient (Figure 2). Moreover, these patients showed re-
verse right ventricular remodeling, as expressed by a signif-
icant decrease of the right ventricular long- and short-axis
diameters (Figure 3). In the 44 patients without significant
TR and without tricuspid annular dilatation at baseline,
the degree of TR and right ventricular dimensions remained
unchanged (Figures 2 and 3). However, in patients with
a dilated tricuspid annulus (40 mm), the degree of TR at
the 2-year follow-up was worse, and the transtricuspid gra-
dient had increased significantly in these 23 patients
(Figure 2). Moreover, this was associated with right ventric-
ular dilatation (Figure 3). Note that these patients did not
undergo tricuspid annuloplasty.Subgroup Analysis of the 2004 Cohort
At the 2-year follow-up, significant reduction of mitral
regurgitation and left atrial and ventricular reverse remodel-
ing was observed in all subgroups of the 2004 cohort (Table
6). In the 2004 cohort, patients underwent annuloplasty of
the mitral and tricuspid valves if grade 3 or 4 TR was pres-
ent at baseline or if the tricuspid annulus was dilated (40
mm), irrespective of the degree of TR preoperatively. Both
in the 21 patients with severe baseline TR and in the 43TABLE 5. Echocardiographic left-sided follow-up of 2002 cohort by subgr
Tricuspid regurgitation
3 (TVP), n ¼ 13
T
tri
Left atrial diameter (mm)
Baseline 50  13
Follow-up 41  10 (P ¼ .001)
Left ventricular end-diastolic diameter (mm)
Baseline 59  11
Follow-up 51  10 (P ¼ .016)
Left ventricular end-systolic diameter (mm)
Baseline 45  10
Follow-up 36  10 (P ¼ .005)
Mitral regurgitation grade
Baseline 3.3  0.6
Follow-up 0.9  0.8 (P<.0001)
P values refer to baseline versus follow-up comparison. TVP, Tricuspid valve annuloplast
1434 The Journal of Thoracic and Cardiovascular Surpatients with tricuspid annular dilatation who underwent
tricuspid annuloplasty, TR and transtricuspid gradient de-
creased significantly at the 2-year follow-up (Figure 4).
Moreover, these patients showed a significant decrease of
right ventricular dimensions, indicating reverse right ven-
tricular remodeling (Figure 5). Patients without important
TR and without tricuspid annular dilatation at baseline did
not undergo tricuspid annuloplasty. The degree of TR regur-
gitation and right ventricular dimensions remained un-
changed in these 38 patients (Figures 4 and 5).DISCUSSION
The main novel findings of the current study are as fol-
lows. In patients with tricuspid annular dilatation undergo-
ing mitral valve reconstruction without concomitant
tricuspid surgery, right ventricular dimensions increased,
and TR was aggravated at the 2-year follow-up. In contrast,
right ventricular reverse remodeling and absence of signif-
icant TR were observed at the 2-year follow-up in patients
with tricuspid annular dilatation who underwent simulta-
neous tricuspid annuloplasty during mitral valve surgery.Incidence and Prognostic Implications of Tricuspid
Valve Regurgitation After Mitral Valve Surgery
Tricuspid valve regurgitation occurs mainly from annular
and right ventricular dilatation, which is often secondary to
left-sided valvular causes, right ventricular volume and
pressure overload, and dilatation of cardiac chambers.8 It
was thought for a long time that this functional TR would
decrease or disappear over time after surgical correction
of mitral regurgitation.16 There is, however, increasing evi-
dence that TR does not always regress after successful sur-
gical treatment ofmitral regurgitation. Often, progression of
TR is observed after mitral valve surgery or appears de novo
during postoperative follow-up.17-19 Kwak and colleagues1
investigated the incidence of significant TR in 335 patients
after left-sided valve surgery (mean follow-up, 11 years;oup
ricuspid regurgitation<3 and
cuspid annulus 40 mm, n ¼ 23
Tricuspid regurgitation<3 and
tricuspid annulus<40 mm, n ¼ 44
52  9 48  9*
46  9 (P ¼ .004) 42  8* (P<.0001)
63  10 59  8*
56  10 (P<.0001) 51  9* (P<.01)
42  13 40  11*
38  13 (P ¼ .037) 33  11* (P<.0001)
3.4  0.5 3.5  0.7*
0.9  0.8 (P<0.0001) 0.5  0.9* (P<.0001)
y. *Not significant for comparison among the 3 groups (analysis of variance).
gery c June 2011
FIGURE 2. Echocardiographic evaluation of tricuspid regurgitation and gradient at baseline and at the 2-year follow-up in the 2002 cohort according to
subgroups. NS, Not significant; TVP, tricuspid valve annuloplasty.
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D52% mitral valve surgery, 22% aortic valve surgery, and
26% combined aortic/mitral valve surgery). The estimated
incidence of TR was 27% and was related to poor out-FIGURE 3. Echocardiographic evaluation of right ventricular (RV) dimension
subgroups. NS, Not significant; TVP, tricuspid valve annuloplasty.
The Journal of Thoracic and Carcome.1 Matsunaga and Duran6 more specifically studied
70 patients with ischemic cardiomyopathy and secondary
mitral regurgitation who underwent coronary artery bypasss at baseline and at the 2-year follow-up in the 2002 cohort according to
diovascular Surgery c Volume 141, Number 6 1435
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TABLE 6. Echocardiographic left-sided follow-up of 2004 cohort by subgroup
Tricuspid
regurgitation
 3 (TVP), n ¼ 21
Tricuspid regurgitation<3 and
tricuspid annulus 40 mm
(TVP), n ¼ 43
Tricuspid regurgitation<3 and
tricuspid annulus<40 mm
(TVP), n ¼ 38
Left atrial diameter (mm)
Baseline 47  7 47  8 49  5*
Follow-up 44  6 (P ¼ .025) 44  8 (P ¼ .008) 44  7* (P<.001)
Left ventricular end-diastolic diameter (mm)
Baseline 60  8 60  8 57  9*
Follow-up 54  10 (P ¼ .007) 54  9 (P<.001) 53  9* (P ¼ .004)
Left ventricular end-systolic diameter (mm)
Baseline 44  12 42  12 40  10*
Follow-up 39  13 (P ¼ .010) 39  12 (P ¼ .019) 36  12* (P ¼ .014)
Mitral regurgitation grade
Baseline 3.3  0.8 3.3  0.6 3.2  0.5*
Follow-up 0.6  0.6 (P<.0001) 0.7  0.8 (P<.0001) 1.0  0.9* (P<.0001)
P values refer to baseline versus follow-up comparison. TVP, Tricuspid valve annuloplasty. *Not significant for comparison among the 3 groups (analysis of variance).
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Dgraft surgery and mitral valve repair with a flexible Duran
ring. The incidence of significant TR was 25% within
the 1-year follow-up and increased to 53% between the
1- and 3-year follow-ups; at late follow-up (>3 years), the
incidence was 74%.6
Combining Mitral Valve Surgery and Tricuspid
Valve Repair
These observations have encouraged surgeons to perform
tricuspid valve repair at the time of mitral valve repair. In
the 1970s, Carpentier and coworkers20 performed tricuspidFIGURE 4. Echocardiographic evaluation of tricuspid regurgitation and gradie
groups. NS, Not significant; TVP, tricuspid valve annuloplasty.
1436 The Journal of Thoracic and Cardiovascular Survalve surgery when medical therapy failed. In the 1980s,
Duran and associates21 suggested that functional TR could
only be ignored in cases of predictable and significant
reduction in pulmonary resistance and that organic disease
always required repair. Nowadays, most surgeons agree that
moderate-to-severe TR should be repaired, and it has been
shown that tricuspid annuloplasty is associated with better
symptomatic results and improved survival.22
Carpentier and coworkers23 were the first to recognize
the importance of tricuspid annular dilatation as an indica-
tion for tricuspid valve repair. Their method of assessingnt at baseline and the 2-year follow-up in the 2004 cohort according to sub-
gery c June 2011
FIGURE 5. Echocardiographic evaluation of right ventricular (RV) dimensions at baseline and the 2-year follow-up in the 2004 cohort according to sub-
groups. NS, Not significant; TVP, tricuspid valve annuloplasty.
Van de Veire et al Acquired Cardiovascular Disease
A
C
Dannular dilatation was surgical exploration of the valve and
the ability of the annulus to admit 3 finger breadths of the
surgeon’s hand, in which case it would be repaired.22 Drey-
fus and colleagues5 suggested that in addition to tricuspid
dilatation, 3 important factors determine whether TR will
occur: preload, afterload, and right ventricular function.
Isolated mitral valve surgery decreases the afterload with-
out correcting tricuspid annular dilatation, and it does not
affect preload or right ventricular function.5 Tricuspid an-
nular dilatation is an ongoing disease process that will
with time lead to severe TR.
Surgical Methods to Treat or Prevent TR
There are 2 principal surgical methods to treat or prevent
TR: the ring annuloplasty, as introduced by Carpentier and
associates,23 and the suture annuloplastymethod,mostly per-
formed as described by De Vega and coworkers.24 Although
either method can be applied for secondary TR, recent long-
term studies suggest that ring annuloplasty repairs are more
robust.22,25,26 Tang and associates2 compared the long-term
results of tricuspid valve repair with or without an annulo-
plasty ring. The authors included 702 patients (74% func-
tional TR), of whom 493 underwent a De Vega procedure
and 209 had annuloplasty. Concomitant procedures con-
sisted of mitral valve surgery in 80%, aortic valve surgery
in 33%, and coronary bypass surgery in 14%. Tricuspid
valve repair without a ring was associated with TR recur-
rence over time. The patients who received a ring had signif-
icantly improved long-term and event-free survival.The Journal of Thoracic and CarResults of Tricuspid Valve Surgery in Patients With
a Dilated Tricuspid Annulus
The relevance of performing tricuspid annuloplasty in
patients with a dilated tricuspid valve annulus has been
demonstrated in several series. Tager and associates27
evaluated 144 patients undergoing mitral valve surgery. Tri-
cuspid annuloplasty was performed in 49 patients, and the
criteria used to indicate this procedure were the presence
of moderate or severe TR or a tricuspid annular diameter,
as assessed with echocardiographic analysis if 30 mm or
greater. Interestingly, those patients who did not show sig-
nificant TR but had a tricuspid annular diameter of 30
mm or greater and in whom tricuspid annuloplasty was
not performed showed an increased prevalence of signifi-
cant TR at follow-up (13%). Sugimoto and colleagues28
demonstrated higher right ventricular volume and pressure,
which are indicative of right-sided heart failure, in patients
undergoing left-sided valvular surgery with a tricuspid
annulus of 40 mm or greater compared with patients with-
out tricuspid annular dilatation. In patients with a dilated
tricuspid annulus undergoing combined mitral and tricuspid
surgery, TR decreased.28 In 2005, Dreyfus and colleagues5
reported on 311 patients who underwent mitral valve repair.
The authors defined a dilated annulus as a diameter of
greater than 70 mm measured peroperatively from the
anteroseptal commissure to the anteroposterior commissure
with a sterile ruler. Tricuspid annuloplasty was performed
only if the tricuspid annular diameter was greater than
twice the normal size (>70 mm), regardless of the gradediovascular Surgery c Volume 141, Number 6 1437
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Dof TR. In patients who did not undergo annuloplasty, TR
increased by more than 2 grades in 48% of patients com-
pared with only 2% of patients who underwent tricuspid
annuloplasty.
The present study focused on patients with severe or-
ganic or functional mitral regurgitation scheduled for mitral
valve repair. The surgical approach for the mitral regurgita-
tion was consistent for all patients. In 2002, only patients
with TR grade 3 or 4 underwent tricuspid annuloplasty.
In these patients TR improved, and right ventricular dimen-
sions decreased. Based on the work of Sugimoto and col-
leagues,28 tricuspid annular dilatation was defined as an
annulus exceeding 40 mm on echocardiographic analysis.
The patients from the 2002 cohort without preoperative
TR grade 3 or 4 but with a dilated annulus had a higher de-
gree of TR at the 2-year follow-up. These findings are well
in line with recent data in comparable patients.29 De Bonis
and associates29 assessed the evolution of functional TR in
95 patients who underwent surgical repair of functional
mitral regurgitation with or without concomitant tricuspid
annuloplasty. Tricuspid annuloplasty was only performed
in 13 patients with preoperative TR grade 3 or 4. At the
6-month echocardiographic follow-up, functional TR was
moderate in 31%, moderate to severe in 10%, and severe
in 2%. The mechanism underlying tricuspid dilatation
was annular dilatation. Moreover, in the present study right
ventricular dimensions increased in the patients with tricus-
pid annular dilatation who did not undergo tricuspid repair.
These data support the observation of Sugimoto and col-
leagues28 that tricuspid annular dilatation is associated
with evidence of right-sided heart failure. In our clinic,
from 2004 on, tricuspid annuloplasty was not only applied
in patients undergoing mitral valve repair with TR grade 3
or 4 but also in patients with tricuspid annular dilatation, ir-
respective of the degree of regurgitation. Reverse right ven-
tricular remodeling and a reduction of TR severity were
observed, supporting a more aggressive approach in these
patients.
CONCLUSIONS
Patients with tricuspid annular dilatation (40 mm) un-
dergoing mitral valve repair without concomitant tricuspid
valve annuloplasty have poor echocardiographic out-
comes. They exhibit right ventricular dilatation and signif-
icantly increased TR at the 2-year follow-up. A more
aggressive surgical approach favoring tricuspid annulo-
plasty in case of tricuspid annular dilatation improves
echocardiographic outcomes significantly. These patients
demonstrate the absence of hemodynamically relevant
TR and right ventricular reverse remodeling at the 2-year
follow-up. Combined mitral repair and tricuspid annulo-
plasty should be considered in patients with tricuspid
annular dilatation despite the absence of important TR at
baseline.1438 The Journal of Thoracic and Cardiovascular SurReferences
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